3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Multiple Myeloma
90
Neoplasms, Plasma Cell
28
Central Nervous System Neoplasms
11
Recurrence
10
Glioblastoma
10
Neoplasms
9
Carcinoma, Hepatocellular
9
Brain Neoplasms
9
Gliosarcoma
8
Melanoma
6
Lung Neoplasms
6
Leukemia
6
Glioma
6
Carcinoma, Non-Small-Cell Lung
6
Waldenstrom Macroglobulinemia
5
Prostatic Neoplasms
5
Lymphoma, Mantle-Cell
5
Myeloproliferative Disorders
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Immunoglobulin Light-chain Amyloidosis
4
Colorectal Neoplasms
4
Carcinoma, Renal Cell
4
Astrocytoma
4
Uveal Melanoma
3
Oligodendroglioma
3
Neuroblastoma
3
Myelodysplastic-Myeloproliferative Diseases
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Interventions
Vincristine
12
Temozolomide
11
Irinotecan
10
Cyclophosphamide
10
Melphalan
8
Filgrastim
8
Etoposide
7
Ifosfamide
6
Granulocyte Colony-Stimulating Factor
6
Doxorubicin
6
Vinorelbine
5
Gemcitabine
5
Busulfan
5
Thiotepa
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Dactinomycin
4
pegfilgrastim
3
liposomal doxorubicin
3
irinotecan sucrosofate
3
fludarabine
3
etoposide phosphate
3
Stem Cell Transplantation
3
Sirolimus
3
Proton Therapy
3
Cisplatin
3
Carboplatin
3
Bone Marrow Transplantation
3
thymoglobulin
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rhabdomyosarcoma
×
Thalidomide
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled